Stellate ganglion block ameliorates vascular calcification by inhibiting endoplasmic reticulum stress

Wei Hao1, Rui Yang2, Yang Yang3

  • 1Department of Anesthesiology, Hebei Provincial Hospital of traditional Chinese Medicine, Shijiazhuang 050011, China.

Life Sciences
|December 7, 2017
PubMed

Insights

Stellate ganglion block (SGB) may treat vascular calcification (VC) by inhibiting sympathetic nervous activity and endoplasmic reticulum stress. This study shows SGB ameliorates VC in rats, offering a potential new therapeutic strategy.

Area of Science:

  • Cardiovascular Research
  • Nephrology
  • Vascular Biology

Background:

  • Vascular calcification (VC) significantly contributes to cardiovascular morbidity and mortality, with limited therapeutic options.
  • Stellate ganglion block (SGB) is a sympathetic blockade procedure known to influence vascular tone.
  • The potential impact of SGB on VC has not been previously investigated.

Purpose of the Study:

  • To investigate the ameliorative effect of SGB on vascular calcification.
  • To explore the underlying mechanisms, including sympathetic activity and endoplasmic reticulum stress (ERS).

Main Methods:

  • Vascular calcification was induced in rats using vitamin D3 plus nicotine (VDN) and in rat aortic vascular smooth muscle cells (VSMC) in vitro.
  • SGB was administered to VDN-induced calcified rats.
  • Alkaline phosphatase (ALP) activity, calcium content, VSMC phenotype transformation, ERS markers, and plasma norepinephrine levels were assessed.

Main Results:

  • SGB treatment ameliorated VDN-induced increases in ALP activity, calcium content, and VSMC osteoblastic transformation in rats.
  • SGB attenuated endoplasmic reticulum stress (ERS) in calcified aortas; ERS inducers blocked SGB's benefits, while ERS inhibitors mimicked them.
  • SGB reduced elevated plasma norepinephrine levels in VDN rats, and in vitro, norepinephrine exacerbated VSMC calcification and ERS.

Conclusions:

  • SGB inhibits sympathetic nervous activity, subsequently preventing ERS activation and ameliorating VC.
  • Sympathetic over-activation plays a critical role in VC pathogenesis.
  • SGB presents a novel therapeutic strategy and target for the prevention and treatment of VC.
Abstract